Latest Pluripotency Stories
MADISON, Wis., June 27, 2011 /PRNewswire/ -- Cellular Dynamics International (CDI) today announced the online publication of an article in the journal Blood demonstrating for the first time a methodology for researchers to access the biology stored in repositories of banked blood samples through the creation of induced pluripotent stem cells (iPSCs).
Researchers have used cutting-edge stem cell technology to correct a genetic defect present in a rare blinding disorder, another step on a promising path that may one day lead to therapies to reverse blindness caused by common retinal diseases such as macular degeneration and retinitis pigmentosa which affect millions of individuals.
CARLSBAD, Calif., June 15, 2011 /PRNewswire/ -- Life Technologies Corporation today announced the launch of CytoTune(TM)-iPS Reprogramming Kit -- research technology that provides far improved efficiency over standard methods to develop induced pluripotent stem cells (iPSCs) from human somatic cells.
FRC Urges Foundation to Issue Retraction, Offer Full Correction WASHINGTON, June 14, 2011 /PRNewswire-USNewswire/ -- Family Research Council (FRC) today criticized the National Science Foundation (NSF) for displaying appalling ignorance about stem cells.
Researchers say human adult and embryonic stem cell research is complementary.
According to a new study, any legislation that slows human embryonic stem cell research is likely to also seriously harm the study of induced pluripotent stem cells.
Researchers at the University of California, San Diego School of Medicine have identified a gene and a novel signaling pathway, both critical for making the first hematopoietic stem cells (HSCs) in developing vertebrate embryos.
MADISON, Wis., June 8, 2011 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI) today announced an agreement with iPS Academia Japan, Inc., who will distribute CDI's iCellÂ® Cardiomyocytes, the first commercially available product based on induced pluripotent stem cells (iPSCs), in Japan.
A team of scientists from Genome Institute of Singapore (GIS) of the Agency for Science, Technology and Research (A*STAR) have shown how proteins involved in controlling genes work together to carry out their functions in stem cells and demonstrated for the very first time, how they can change interaction partners to make other types of cells.
FREMONT, Calif., May 18, 2011 /PRNewswire/ -- Biomerix Corporation and Cellon today announced a strategic distribution agreement for the Biomerix 3D Scaffold, a novel three-dimensional tissue scaffold.
- A trick or prank.